|Previous Section||Back to Table of Contents||Lords Hansard Home Page|
To ask Her Majesty's Government further to the Written Answer by the Parliamentary Under-Secretary of State for Communities and Local Government, Barbara Follett, on 9 December 2009 (HC Deb, col. 390W), what was the average purchase price, excluding value added tax, of a 500 sheet ream of white A4 80 gsm photocopier paper paid by (a) the Equality and Human Rights Commission, and (b) the Government Equalities Office, in the latest period for which figures are available. [HL1174]
The Chancellor of the Duchy of Lancaster (Baroness Royall of Blaisdon): The current purchase price for a 500-sheet ream of white A4 80 gsm photocopier paper paid by (a) the Equality and Human Rights Commission was £1.96 and (b) the Government Equalities Office was £2.17.
To ask Her Majesty's Government whether the United Kingdom would be required, although not a member of the eurozone, to make a financial
27 Jan 2010 : Column WA345
The Financial Services Secretary to the Treasury (Lord Myners): Membership of the European Union does not impose any obligation on the UK to contribute to any financial rescue, or accept the debt obligations, of any EU member state. There has been no request for UK support. Any such requests are considered on their individual merits.
To ask Her Majesty's Government what the National Health Service and Department of Health combined expenditure was on (a) pharmaceuticals, and (b) influenza and other vaccines, in cash and real terms in (1) 1996-97, (2) 2003-04, (3) 2005-06 and (4) 2008-09; and what the estimated expenditure is in 2009-10 for those items. [HL1344]
Baroness Thornton: Pharmaceuticals (drugs) expenditure includes National Health Service expenditure in primary care and the Hospital and Community Health Service (HCHS). The primary care expenditure reflects amounts paid to pharmacy and appliance contractors and amounts authorised for dispensing doctors and personal administration in England. This includes expenditure on the seasonal influenza and adult pneumococcal vaccines, which are procured and administered by general practitioners and other contractors.
|Table 1: NHS expenditure on drugs|
|£ million||NHS drugs expenditure|
1. Government accounting policy changed in 2000-01; as a result, figures prior to 2000-01 are not strictly comparable to figures thereafter. Expenditure prior to 2000-01 represents the amounts paid between April to March for medicines and appliances and relate to prescriptions dispensed between March and February. This is due to the delay in prescription processing and payment calculations. From 2000-01, figures represent the actual cost of the prescriptions for medicines and appliances dispensed in the period April to March.
2. Year-to-date primary care figures have been provided for 2009-10. We do not have HCHS figures, which are sourced from
27 Jan 2010 : Column WA346
Additionally, the department provides centrally purchased vaccines for the NHS routine childhood immunisation programme and catch up programmes, vaccines against anthrax, rabies, smallpox, and the swine influenza vaccination programme 2009-10. The department is not able to divulge expenditure on swine influenza vaccine as it would violate confidentiality clauses in the contracts with the manufacturers. The available information about the department's expenditure on vaccines for England (not including swine influenza vaccine) is given in Table 2 in cash and real terms (2008-09 base year).
|Table 2: Department of Health expenditure on vaccines|
1. Where relevant, figures for England have been calculated as 84 per cent. of expenditure on vaccines for the United Kingdom. Childhood vaccines and smallpox vaccine are purchased for the UK. Anthrax and rabies vaccines are purchased for England and Wales.
The vaccines provided for NHS programmes have changed over the period of time shown in the table. For example, the higher level of expenditure in 2008-09 partly reflects the addition of human papilloma virus vaccination against cervical cancer.
Information about vaccine expenditure in 1996-97 is not available. It has not been possible to confirm whether or not records of vaccine expenditure for 1996-97 have been retained centrally by the department and there is no obligation for such records of this age to be retained.
Baroness Thornton: The department does not collect detailed expenditure information in these areas since, subject to delivering national targets, there is local discretion on how the funding is spent. However, for public health and prevention, a report by Health England shows (mostly using end of year information) expenditure in England on public health and prevention
27 Jan 2010 : Column WA347
Table 3 in that report is replicated here as follows, entitled Table 1, and provides a breakdown of spending based as closely as possible on Organisation for Economic Co-operation and Development (OECD) definitions
|Table 1: Detailed Prevention Expenditure in England 2006-07|
|Primary prevention||Secondary prevention||Total £m|
|Next Section||Back to Table of Contents||Lords Hansard Home Page|